Gait Evaluation in Haemophiliac Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT00824798
First received: January 16, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted

January 16, 2009
January 16, 2009
January 2009
January 2011   (final data collection date for primary outcome measure)
evaluate specific changes in gait in patients suffering from haemophilic arthropathy [ Time Frame: 01/2009 ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Gait Evaluation in Haemophiliac Patients
Gait Evaluation in Haemophiliac Patients

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

haemophilia A or B, mild, moderate or severe.

  • Hemophilia A
  • Hemophilia B
Not Provided
haemophiliacs A and B
haemophiliacs A and B mild, moderate or severe from 4 to 80 years old, with or without inhibitors.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
January 2012
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • haemophilia A or B
  • aged more than 4 years

Exclusion Criteria:

  • impossibility to walk on a treadmill
  • recent joint haemarthrosis or muscle haematoma
Male
4 Years to 80 Years
Yes
Contact: sebastien lobet sebastien.lobet@uclouvain.be
Belgium
 
NCT00824798
READ-LOBET-02, READ-LOBET-02
Yes
Cliniques universitaires Saint-Luc, service d'hématologie
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not Provided
Not Provided
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP